Reported 1 day ago
Novo Nordisk has hired Greg Miley, a seasoned U.S. pharmaceutical executive, as its new global head of corporate affairs in response to increasing drug pricing pressure from President Donald Trump. Miley, who previously served as senior vice president of government affairs at AbbVie, will relocate to Denmark next month and is expected to strengthen Novo's relationship with the Trump administration as the company navigates political challenges in the U.S. market, where it competes with rivals like Eli Lilly.
Source: YAHOO